Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Hands-On nerve technique ease Fibromyalgia's grip?

NCT ID NCT07825506

Symptom relief Sponsor: Pontificia Universidad Catolica de Chile Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 17, 2026 · Last updated Sep 18, 2026 · Updated 1 time

Summary

Researchers in Chile are testing whether adding neural mobilization, a physical therapy technique that targets nerve movement, to standard fibromyalgia care improves daily function and reduces pain more than standard care alone. The trial enrolls 20 women aged 18 and older with a fibromyalgia diagnosis. Over 12 weeks, one group receives conventional treatment plus neural mobilization, while the other receives only conventional treatment. The main measure is change in the Revised Fibromyalgia Impact Questionnaire, which scores how much fibromyalgia affects daily life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
neural mobilization, a hands-on physical therapy technique that aims to improve how nerves move and glide
What this could lead to
If neural mobilization helps, it could offer a low-risk add-on to standard fibromyalgia care that improves daily function and eases pain.
What could go wrong
This is a small study of 20 women, so results may not hold for everyone with fibromyalgia. Physical therapy can sometimes flare up pain, and the trial may not show a clear benefit over conventional treatment alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2026

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women aged 18 or older. * Medical diagnosis of fibromyalgia. * Ability to understand the study and sign informed consent. * Stable drug treatment for the 4 weeks prior. Exclusion Criteria: * Pregnancy. * Active cancer or unstable systemic disease. * Severe decompensated psychiatric disorder. * Active substance dependence. * Inability to participate in therapeutic exercise or complete evaluations. * For the subsample with biopsy: use of anticoagulants, allergy to lidocaine, or active infection at the site.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Disabilities are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fibromyalgia Motor Activity Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Disabilities Fibromyalgia Pain Women

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Pontificia Universidad Católica de Chile

    Santiago, Santiago Metropolitan, 8320000, Chile

More trials for these conditions

Other studies related to the condition(s) this trial covers.